Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11497 | 977 | 44.8 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
365 | 3 | MICROTUBULES//MITOSIS//KINETOCHORE | 34118 |
540 | 2 | KINETOCHORE//MITOSIS//CENTROSOME | 14738 |
11497 | 1 | POLO LIKE KINASE 1//PLK1//POLO LIKE KINASE | 977 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | POLO LIKE KINASE 1 | authKW | 2261924 | 10% | 75% | 97 |
2 | PLK1 | authKW | 2160774 | 14% | 52% | 132 |
3 | POLO LIKE KINASE | authKW | 1715131 | 10% | 58% | 94 |
4 | POLO BOX DOMAIN | authKW | 950732 | 3% | 89% | 34 |
5 | BI 2536 | authKW | 542566 | 3% | 69% | 25 |
6 | VOLASERTIB | authKW | 410539 | 2% | 77% | 17 |
7 | PLK3 | authKW | 291682 | 1% | 67% | 14 |
8 | BI 6727 | authKW | 281274 | 1% | 100% | 9 |
9 | POLO | authKW | 235023 | 2% | 40% | 19 |
10 | PLK2 | authKW | 234380 | 2% | 50% | 15 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 5466 | 39% | 0% | 377 |
2 | Oncology | 3235 | 31% | 0% | 300 |
3 | Biochemistry & Molecular Biology | 1541 | 35% | 0% | 342 |
4 | Chemistry, Medicinal | 394 | 7% | 0% | 65 |
5 | Genetics & Heredity | 189 | 7% | 0% | 70 |
6 | Developmental Biology | 95 | 2% | 0% | 23 |
7 | Biophysics | 48 | 4% | 0% | 36 |
8 | Hematology | 39 | 3% | 0% | 27 |
9 | Pharmacology & Pharmacy | 36 | 6% | 0% | 62 |
10 | Reproductive Biology | 19 | 1% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELL CYCLE SIGNAL TRANSDUCT | 86809 | 1% | 56% | 5 |
2 | CANC CAMPAIGN CELL CYCLE GENET GRP | 70317 | 0% | 75% | 3 |
3 | BIOL MECHANISMS SECT | 62505 | 0% | 100% | 2 |
4 | GYNECOL MOL ONCOL GYNECOL | 62505 | 0% | 100% | 2 |
5 | DELAWARE CARDIOVASC | 46876 | 0% | 50% | 3 |
6 | IMMUNE VASC CELL NETWORK | 41669 | 0% | 67% | 2 |
7 | MOL DISCOVERY PROGRAM | 34084 | 1% | 18% | 6 |
8 | ALLGEMEINES KRANKENHAUS CELLE MED | 31253 | 0% | 100% | 1 |
9 | ALTANA PHARMA AG | 31253 | 0% | 100% | 1 |
10 | BIOL CELLULAIRE DEV UMR 7622 | 31253 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY SERIES | 15804 | 5% | 1% | 50 |
2 | CELL CYCLE | 3835 | 1% | 1% | 9 |
3 | MOLECULAR CANCER THERAPEUTICS | 2461 | 2% | 0% | 18 |
4 | ONCOGENE | 2194 | 4% | 0% | 36 |
5 | CELL DIVISION | 1360 | 0% | 1% | 3 |
6 | ONCOTARGET | 1312 | 2% | 0% | 23 |
7 | MOLECULAR AND CELLULAR BIOLOGY | 1058 | 3% | 0% | 28 |
8 | JOURNAL OF BIOLOGICAL CHEMISTRY | 634 | 6% | 0% | 59 |
9 | AMERICAN JOURNAL OF CANCER RESEARCH | 627 | 0% | 1% | 4 |
10 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 619 | 2% | 0% | 23 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | POLO LIKE KINASE 1 | 2261924 | 10% | 75% | 97 | Search POLO+LIKE+KINASE+1 | Search POLO+LIKE+KINASE+1 |
2 | PLK1 | 2160774 | 14% | 52% | 132 | Search PLK1 | Search PLK1 |
3 | POLO LIKE KINASE | 1715131 | 10% | 58% | 94 | Search POLO+LIKE+KINASE | Search POLO+LIKE+KINASE |
4 | POLO BOX DOMAIN | 950732 | 3% | 89% | 34 | Search POLO+BOX+DOMAIN | Search POLO+BOX+DOMAIN |
5 | BI 2536 | 542566 | 3% | 69% | 25 | Search BI+2536 | Search BI+2536 |
6 | VOLASERTIB | 410539 | 2% | 77% | 17 | Search VOLASERTIB | Search VOLASERTIB |
7 | PLK3 | 291682 | 1% | 67% | 14 | Search PLK3 | Search PLK3 |
8 | BI 6727 | 281274 | 1% | 100% | 9 | Search BI+6727 | Search BI+6727 |
9 | POLO | 235023 | 2% | 40% | 19 | Search POLO | Search POLO |
10 | PLK2 | 234380 | 2% | 50% | 15 | Search PLK2 | Search PLK2 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | STREBHARDT, K , (2010) MULTIFACETED POLO-LIKE KINASES: DRUG TARGETS AND ANTITARGETS FOR CANCER THERAPY.NATURE REVIEWS DRUG DISCOVERY. VOL. 9. ISSUE 8. P. 643 -U24 | 159 | 65% | 277 |
2 | LEE, KS , BURKE, TR , PARK, JE , BANG, JK , LEE, E , (2015) RECENT ADVANCES AND NEW STRATEGIES IN TARGETING PLK1 FOR ANTICANCER THERAPY.TRENDS IN PHARMACOLOGICAL SCIENCES. VOL. 36. ISSUE 12. P. 858 -877 | 101 | 81% | 6 |
3 | PEZUK, JA , VALERA, ET , BRASSESCO, MS , (2016) PLK1 INHIBITION: PROSPECTIVE ROLE FOR THE TREATMENT OF PEDIATRIC TUMORS.CURRENT DRUG TARGETS. VOL. 17. ISSUE 14. P. 1661 -1672 | 108 | 80% | 0 |
4 | VAN DEN BOSSCHE, J , LARDON, F , DESCHOOLMEESTER, V , DE PAUW, I , VERMORKEN, JB , SPECENIER, P , PAUWELS, P , PEETERS, M , WOUTERS, A , (2016) SPOTLIGHT ON VOLASERTIB: PRECLINICAL AND CLINICAL EVALUATION OF A PROMISING PLK1 INHIBITOR.MEDICINAL RESEARCH REVIEWS. VOL. 36. ISSUE 4. P. 749 -786 | 83 | 88% | 2 |
5 | STREBHARDT, K , ULLRICH, A , (2006) OPINION - TARGETING POLO-LIKE KINASE 1 FOR CANCER THERAPY.NATURE REVIEWS CANCER. VOL. 6. ISSUE 4. P. 321 -330 | 85 | 72% | 448 |
6 | ARCHAMBAULT, V , LEPINE, G , KACHANER, D , (2015) UNDERSTANDING THE POLO KINASE MACHINE.ONCOGENE. VOL. 34. ISSUE 37. P. 4799 -4807 | 84 | 72% | 19 |
7 | LIU, XQ , (2015) TARGETING POLO-LIKE KINASES: A PROMISING THERAPEUTIC APPROACH FOR CANCER TREATMENT.TRANSLATIONAL ONCOLOGY. VOL. 8. ISSUE 3. P. 185 -195 | 66 | 87% | 23 |
8 | LIU, ZX , SUN, QR , WANG, XS , (2017) PLK1, A POTENTIAL TARGET FOR CANCER THERAPY.TRANSLATIONAL ONCOLOGY. VOL. 10. ISSUE 1. P. 22 -32 | 96 | 77% | 0 |
9 | HELMKE, C , BECKER, S , STREBHARDT, K , (2016) THE ROLE OF PLK3 IN ONCOGENESIS.ONCOGENE. VOL. 35. ISSUE 2. P. 135 -147 | 84 | 62% | 6 |
10 | YIM, H , ERIKSON, RL , (2014) PLK1-TARGETED THERAPIES IN TP53-OR RAS-MUTATED CANCER.MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH. VOL. 761. ISSUE . P. 31 -39 | 86 | 84% | 4 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 6479 | AURORA KINASE//AURORA A//AURORA KINASE INHIBITOR |
2 | 3081 | CENTROSOME//CENTRIOLE//GAMMA TUBULIN |
3 | 1972 | SPINDLE ASSEMBLY CHECKPOINT//MAD2//CDC20 |
4 | 10900 | CYTOKINESIS//CENTRAL SPINDLE//CENTRALSPINDLIN |
5 | 24379 | NEK2//NIMA//NEK6 |
6 | 2551 | MPF//CDC2//GREATWALL |
7 | 8368 | CDC14//CYTOKINESIS//FISSION YEAST |
8 | 15937 | CDC25B//CDC25 PHOSPHATASE//CDC25A |
9 | 23620 | KINESIN SPINDLE PROTEIN//EG5//KSP |
10 | 28520 | MAP4K4//TNIK//MST3 |